Nanomedicines are extensively explored for cancer therapy. By delivering drug molecules
more efficiently to pathological sites and by attenuating their accumulation in healthy organs …

Cell therapies, such as immune cell and stem cell therapies, are being preclinically and
clinically explored for the treatment of various diseases, but are often limited by low efficacy …

Tumour-associated neutrophils can exert antitumour effects but can also assume a pro-
tumoural phenotype in the immunosuppressive tumour microenvironment. Here we show …

Natural killer (NK) cell therapies have emerged as a potential therapeutic approach to
various cancers. Their efficacy, however, is limited by their low persistence and anergy …

Spinal cord injury (SCI) is a traumatic condition that results in impaired motor and sensory
function. Ferroptosis is one of the main causes of neural cell death and loss of neurological …

Cell-mediated nanoparticle delivery systems (CMNDDs) utilize cells as carriers to deliver the
drug-loaded nanoparticles. Unlike the traditional nanoparticle drug delivery approaches …

Autoimmune disorders have risen to be among the most prevalent chronic diseases across
the globe, affecting approximately 5–7% of the population. As autoimmune diseases steadily …

Adoptive cell therapies are dramatically altering the treatment landscape of cancer.
However, treatment of solid tumors remains a major unmet need, in part due to limited …

Monocytes play a critical role in the initiation and progression of multiple sclerosis (MS).
Recent research indicates the importance of considering the roles of monocytes in the …

Multiple sclerosis (MS) is a neurodegenerative autoimmune disease characterized by the
destruction of the myelin sheath of the neuronal axon in the central nervous system. Many …